232 related articles for article (PubMed ID: 30045709)
1. Decrease of 5-hydroxymethylcytosine and TET1 with nuclear exclusion of TET2 in small intestinal neuroendocrine tumors.
Barazeghi E; Prabhawa S; Norlén O; Hellman P; Stålberg P; Westin G
BMC Cancer; 2018 Jul; 18(1):764. PubMed ID: 30045709
[TBL] [Abstract][Full Text] [Related]
2. MYC deregulates TET1 and TET2 expression to control global DNA (hydroxy)methylation and gene expression to maintain a neoplastic phenotype in T-ALL.
Poole CJ; Lodh A; Choi JH; van Riggelen J
Epigenetics Chromatin; 2019 Jul; 12(1):41. PubMed ID: 31266538
[TBL] [Abstract][Full Text] [Related]
3. 5-Hydroxymethylcytosine discriminates between parathyroid adenoma and carcinoma.
Barazeghi E; Gill AJ; Sidhu S; Norlén O; Dina R; Palazzo FF; Hellman P; Stålberg P; Westin G
Clin Epigenetics; 2016; 8():31. PubMed ID: 26973719
[TBL] [Abstract][Full Text] [Related]
4. Chronic ethanol-mediated hepatocyte apoptosis links to decreased TET1 and 5-hydroxymethylcytosine formation.
Ji C; Nagaoka K; Zou J; Casulli S; Lu S; Cao KY; Zhang H; Iwagami Y; Carlson RI; Brooks K; Lawrence J; Mueller W; Wands JR; Huang CK
FASEB J; 2019 Feb; 33(2):1824-1835. PubMed ID: 30188753
[TBL] [Abstract][Full Text] [Related]
5. TET2-Mediated Spatiotemporal Changes of 5-Hydroxymethylcytosine During Organogenesis in the Late Mouse Fetus.
Li X; Xie F; Jin J; Wu Y; Luo Z; Zhang F; Zhang S; Chen D; Liu A
Anat Rec (Hoboken); 2019 Jun; 302(6):954-963. PubMed ID: 30369084
[TBL] [Abstract][Full Text] [Related]
6. A role for
Barazeghi E; Gill AJ; Sidhu S; Norlén O; Dina R; Palazzo FF; Hellman P; Stålberg P; Westin G
Endocr Relat Cancer; 2017 Jul; 24(7):329-338. PubMed ID: 28642344
[TBL] [Abstract][Full Text] [Related]
7. Nuclear exclusion of TET1 is associated with loss of 5-hydroxymethylcytosine in IDH1 wild-type gliomas.
Müller T; Gessi M; Waha A; Isselstein LJ; Luxen D; Freihoff D; Freihoff J; Becker A; Simon M; Hammes J; Denkhaus D; zur Mühlen A; Pietsch T; Waha A
Am J Pathol; 2012 Aug; 181(2):675-83. PubMed ID: 22688054
[TBL] [Abstract][Full Text] [Related]
8. TCEB3C a putative tumor suppressor gene of small intestinal neuroendocrine tumors.
Edfeldt K; Ahmad T; Åkerström G; Janson ET; Hellman P; Stålberg P; Björklund P; Westin G
Endocr Relat Cancer; 2014 Apr; 21(2):275-84. PubMed ID: 24351681
[TBL] [Abstract][Full Text] [Related]
9. A plausible role for actin gamma smooth muscle 2 (ACTG2) in small intestinal neuroendocrine tumorigenesis.
Edfeldt K; Hellman P; Westin G; Stalberg P
BMC Endocr Disord; 2016 Apr; 16():19. PubMed ID: 27107594
[TBL] [Abstract][Full Text] [Related]
10. Values of 5mC, 5hmC, and TET2 for identifying the presence and progression of breast precancerous lesion.
Zhang Z; Jin Y; Zhang W; Chu C; Zhang K; Gao X; Zhou J; Zou L; Tang F; Wang H; Zou Q
J Clin Lab Anal; 2020 May; 34(5):e23162. PubMed ID: 31867779
[TBL] [Abstract][Full Text] [Related]
11. Overexpression of TET dioxygenases in seminomas associates with low levels of DNA methylation and hydroxymethylation.
Benešová M; Trejbalová K; Kučerová D; Vernerová Z; Hron T; Szabó A; Amouroux R; Klézl P; Hajkova P; Hejnar J
Mol Carcinog; 2017 Aug; 56(8):1837-1850. PubMed ID: 28218476
[TBL] [Abstract][Full Text] [Related]
12. EZH2 presents a therapeutic target for neuroendocrine tumors of the small intestine.
Barazeghi E; Hellman P; Norlén O; Westin G; Stålberg P
Sci Rep; 2021 Nov; 11(1):22733. PubMed ID: 34815475
[TBL] [Abstract][Full Text] [Related]
13. Specific functions of TET1 and TET2 in regulating mesenchymal cell lineage determination.
Cakouros D; Hemming S; Gronthos K; Liu R; Zannettino A; Shi S; Gronthos S
Epigenetics Chromatin; 2019 Jan; 12(1):3. PubMed ID: 30606231
[TBL] [Abstract][Full Text] [Related]
14. The expression of TET3 regulated cell proliferation in HepG2 cells.
Zhong X; Liu D; Hao Y; Li C; Hao J; Lin C; Shi S; Wang D
Gene; 2019 May; 698():113-119. PubMed ID: 30836118
[TBL] [Abstract][Full Text] [Related]
15. TET enzymes are successively expressed during human spermatogenesis and their expression level is pivotal for male fertility.
Ni K; Dansranjavin T; Rogenhofer N; Oeztuerk N; Deuker J; Bergmann M; Schuppe HC; Wagenlehner F; Weidner W; Steger K; Schagdarsurengin U
Hum Reprod; 2016 Jul; 31(7):1411-24. PubMed ID: 27141042
[TBL] [Abstract][Full Text] [Related]
16. 5-Hydroxymethylcytosine expression is associated with poor survival in cervical squamous cell carcinoma.
Zhang LY; Han CS; Li PL; Zhang XC
Jpn J Clin Oncol; 2016 May; 46(5):427-34. PubMed ID: 26851753
[TBL] [Abstract][Full Text] [Related]
17. Downregulation of 5-hydroxymethylcytosine is an early event in pancreatic tumorigenesis.
Fujikura K; Alruwaii ZI; Haffner MC; Trujillo MA; Roberts NJ; Hong SM; Macgregor-Das A; Goggins MG; Roy S; Meeker AK; Ding D; Wright M; He J; Hruban RH; Wood LD
J Pathol; 2021 Jul; 254(3):279-288. PubMed ID: 33870509
[TBL] [Abstract][Full Text] [Related]
18. Dynamic expression of TET1, TET2, and TET3 dioxygenases in mouse and human placentas throughout gestation.
Rakoczy J; Padmanabhan N; Krzak AM; Kieckbusch J; Cindrova-Davies T; Watson ED
Placenta; 2017 Nov; 59():46-56. PubMed ID: 29108636
[TBL] [Abstract][Full Text] [Related]
19. Association of high 5-hydroxymethylcytosine levels with Ten Eleven Translocation 2 overexpression and inflammation in Sjögren's syndrome patients.
Lagos C; Carvajal P; Castro I; Jara D; González S; Aguilera S; Barrera MJ; Quest AFG; Bahamondes V; Molina C; Urzúa U; Hermoso MA; Leyton C; González MJ
Clin Immunol; 2018 Nov; 196():85-96. PubMed ID: 29894742
[TBL] [Abstract][Full Text] [Related]
20. TET-mediated hydroxymethylcytosine at the Pparγ locus is required for initiation of adipogenic differentiation.
Yoo Y; Park JH; Weigel C; Liesenfeld DB; Weichenhan D; Plass C; Seo DG; Lindroth AM; Park YJ
Int J Obes (Lond); 2017 Apr; 41(4):652-659. PubMed ID: 28100914
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
